Nyxoah S.A. (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
6.95
-0.70 (-9.15%)
Mar 31, 2025, 2:24 PM EDT - Market open
Nyxoah Revenue
In the year 2024, Nyxoah had annual revenue of 4.52M EUR with 3.98% growth. Nyxoah had revenue of 1.26M in the quarter ending December 31, 2024, a decrease of -30.76%.
Revenue (ttm)
4.52M EUR
Revenue Growth
+3.98%
P/S Ratio
56.18
Revenue / Employee
24,624 EUR
Employees
184
Market Cap
262.95M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
NYXH News
- 3 days ago - Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. - Accesswire
- 5 days ago - FDA Issues Nyxoah an Approvable Letter for its Genio® System - GlobeNewsWire
- 17 days ago - Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - GlobeNewsWire
- 20 days ago - Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - GlobeNewsWire
- 27 days ago - Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 5 weeks ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewsWire
- 2 months ago - Publication relating to transparency notifications - GlobeNewsWire